Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (CSE:
$KBEV.C) (OTC: $KALY) (OTC: $PURA) (NASDAQ: $NEPT) (NYSE: $ACB) (CSE: $OH.C)
(TSX: $APHA.TO)
Delta, Kelowna, BC –July 18,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/07181KBEV-KALY-PURA-NEPT-ACB-OH-APHA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
Koios
Beverage Corp. (CSE: KBEV) (OTC: KBEVF) announced that
it has made several key developments with respect to its proposed line of
functional beverages containing broad-spectrum hemp extract CBD. In a press
release dated September
4, 2018, the Company
announced its plans to release a functional beverage, which would be infused
with CBD to enhance the beverage's effects. Koios will leverage its existing
relationship with Colorado-based Keef Brands in the development of this product, with Keef Brands to supply crystalized,
water-soluble CBD which will be added to Koios' existing Fit SodaTM line of functional beverages.
Starting tomorrow, the Company and Keef Brands will produce several test batches of the proposed
CBD beverage, with user trials to begin shortly afterward.
The
addition of CBD to Koios' proprietary stack of nutrients, amino acids, and
electrolytes in its Fit SodaTM line of beverages is expected to
improve the product's effects. Pending completion of further testing, the
Company also plans to integrate CBD into its eponymous KOIOS beverage lineup at
a later date. When the proposed beverage is released, Fit SodaTM
will be available both with and without CBD.
On
Friday, July 19, 2019, Koios will start production of several test batches of
its Fit SodaTM product with crystallized CBD supplied by Keef
Brands. Upon completion of this production, the Company will be distributing
the products from the test batch to select existing clients for trial purposes.
Additionally, Koios has consumer trials planned with individuals in its local
community. Feedback derived from these trials will be utilized to further
develop the proposed CBD beverage and prepare it for commercial production and
distribution under the Fit SodaTM banner. The water-soluble CBD
crystals supplied through Keef Brands have shown consistent potency and
efficacy results in Keef's internal evaluation efforts of numerous
water-soluble CBD solutions over the past year.
Large-scale distribution of CBD-enhanced
Fit SodaTM will be contemplated by Koios based on feedback that the
Company receives from the test batches being produced beginning tomorrow.
Developments with respect to this large-scale distribution, including interest
received from retail vendors, will be announced in a future press release.
Koios Chief Executive Officer Chris
Miller added, "I believe we made the right choice with respect to waiting
until now to finalize our development of a CBD-enhanced functional beverage.
Between an ambiguous legal landscape for CBD, as well as an unbelievable amount
of pseudoscience and false claims about this cannabinoid, last year simply was
not the right time for us to finalize such a product or bring it to market. By
holding off, we have been able to put our full focus on our existing products
and relationships with large-scale retailers. Additionally, it gave us the
opportunity to observe others' successes and failures in developing or
releasing CBD products, from which we are learning, for when we ultimately
release our beverages with CBD. We are thankful for being able to continue
working with Keef Brands as such a highly-respected firm in the beverages
space, and we are eagerly anticipating positive results from the test batch
trials."
Kali-Extracts (OTC:
KALY) announced
today that the company is working with its
partner Puration, Inc. (OTC:
PURA) on developing a CBD extraction for
PURA’s plans to introduce a CBD infused beer with an existing beer producer.
KALY has a U.S. Patent for Cannabis Extraction and partners with PURA now on 10
mg and 25 mg CBD infused sports beverages. PURA is a leading CBD infused
beverage company having produced over $1 million in CBD Beverages in the United
States last year. PURA has targeted $4 million in sales for 2019.
A research report out this week
highlights the current alcohol producer trend to pursue cannabis beverages with
the continued liberalization of cannabis laws.
KALY is primarily a biopharmaceutical
company focused on discovering, developing and commercializing novel
therapeutics from a proprietary cannabinoid product platform in a broad range
of disease areas.
KALY has a deep pipeline of cannabinoid
product candidates including four distinct compounds. KALY has completed the
first stage of clinical development and testing for a Chronic Obstructive
Pulmonary Disease (COPD) therapy and is currently conducting phase one
development and trials for compounds targeting Cancer Pain Management, Type 2
Diabetes and Epilepsy.
Aurora Cannabis Inc. (NYSE:
ACB) (TSX:
ACB), the Canadian company defining the
future of cannabis worldwide, announced
today that the Company has been selected as
the only winner of the Italian government's public tender to supply medical
cannabis in Italy. The supply contract is expected to be signed in September
2019.
The tender saw five companies
participate, with Aurora selected as the sole winner of three lots to supply
the Italian market, which is one of the most strictly regulated medical
cannabis markets in the world. The decision will see Aurora continue to supply
the Italian market with medical cannabis, as it has done for the past 15
months, further to winning the first ever tender there in January 2018. All
submissions from competing cannabis companies were disqualified because they
were unable to meet the stringent requirements of the tender.
Aurora will supply a minimum of 400 kg of
medical cannabis over the two-year contract
with the cannabis coming from its Canadian EU GMP certified facilities
and imported to Italy through Aurora Deutschland, its wholly-owned European
subsidiary. The cannabis will be sold to Agenzia Industrie Difesa (an agency of
the Italian Ministry of Defense) for distribution to local pharmacies, who
dispense directly to patients.
"We're committed to building a
successful, long-term medical cannabis market in Italy," said Neil Belot,
Aurora's Chief Global Business Development Officer. "We want to continue
to build our connection with patients and pharmacies in the Italian market, who
have come to know and appreciate our products over most of the past two years.
I'm extremely proud of our team. This win reflects our ability to navigate
complex international regulations and work with governments around the world to
establish ourselves as a trusted partner."
Axel Gille, Managing Director of Aurora
Deutschland GmbH, added, "The well-being of our patients is our top
priority and we're dedicated to ensuring they have access to a consistent
supply of safe, high-quality medical cannabis. We look forward to expanding our
presence in Italy and continuing to work with other international regulators to
ensure patients around the world have access to our high-quality medical
cannabis."
Neptune Wellness Solutions Inc. (NASDAQ:
NEPT) (TSX:
NEPT), a North American leader in
cannabinoids extraction, formulation and turnkey packaging solutions, has
completed a private placement with both existing and new institutional
investors, led by Perceptive Advisors, resulting in gross proceeds to the
Company of US$41.4 million. John Moretz, Chairman of the Board, and Michael
Cammarata, President and CEO of Neptune, invested US$5.0 million in the
aggregate as part of this Offering. Upon closing of the Offering, the Company
issued an aggregate of 9,415,910 common shares of the Company at a purchase
price of US$4.40 per Share.
"The Board joins me in thanking
investors who participated in this offering and in welcoming our new
shareholders to Neptune. Given recent contracts and the announced extraction
capacity expansion plans, we are highly confident in the strength of Neptune's
business outlook", said John Moretz. "My incremental investment in
Neptune reflects my conviction in our new CEO and management team and their
ability to execute on Neptune's strategy. We opted for this accelerated
financing structure to stay on track with the previously announced SugarLeaf
closing timeline."
A portion of the net proceeds from the
Offering is expected to be used by the Company to fund the initial
consideration for the acquisition of the assets of SugarLeaf Labs LLC and
Forest Remedies LLC (collectively "SugarLeaf"), while the balance of
such net proceeds is expected to be used for working capital and general
corporate purposes. Neptune expects the SugarLeaf transaction to close on or before
July 31, 2019.
"This financing comes at a pivotal
point in the Company's cannabis growth trajectory, particularly given the need
to expand our current annual capacity of 200,000 kg, which is fully contracted
for both fiscal 2020 and fiscal 2021," said Mr. Cammarata. "With this
in mind, we look forward to closing the SugarLeaf transaction, which brings
U.S.-based capacity, efficient production of high-quality extracts, and strong
supplier relationships, all of which create a strong value proposition for our
customers."
CannaRoyalty Corp. d/b/a Origin House (CSE:
OH) (OTCQX:
ORHOF),
a North American cannabis products and brands company today
announced preliminary unaudited revenue of
approximately $21 million1 for the second quarter ended June 30,
2019, at an approximate gross margin, excluding fair value items, of 17%1.
All figures are reported in Canadian dollars, unless otherwise indicated.
The California market has grown in 2019,
with an increase in the number of licensed dispensaries since December 20182
and a more stable regulatory environment than in 2018. Origin House's progress
during the first six months of the year has primarily been driven by its
focused strategy to capitalize on the statewide California platform it
established over the past two years.
Marc Lustig, Chairman and CEO of Origin
House commented, "Origin House has continued to gain momentum as our team
leveraged the California-focused platform we have built over the past two years
to drive another quarter of record revenue along with steady progress on gross
margin. As expressed previously, we strongly believe that 2019 will mark an
inflection point both for the California market and Origin House as a whole and
the numbers are proving this out."
Origin House plans to release its full
financial results for the second quarter ended June 30, 2019 during the second
half of August and will be coordinating its financial results release with the
release of Cresco Labs' financial results.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) will
release results for the fourth quarter and
twelve months ended May 31, 2019 on August 1, 2019 after market close.
Aphria executives will host a conference
call to discuss these results at 5:00 pm ET. To listen to the live call, dial
(888) 231-8191 from Canada and the U.S. or (647) 427-7450 from International
locations and use the passcode 5081017. A telephone replay will be available
approximately two hours after the call concludes through August 15, 2019. To
access the recording dial (855) 859-2056 and use the passcode 5081017.
There will also be a simultaneous live
webcast available on the Investors section of Aphria's website at aphriainc.com. The webcast will be archived for 30 days.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment